Orally administered adsorbent

The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention i...

Full description

Saved in:
Bibliographic Details
Main Authors Ohtaki, Akihito, Nishiwaki, Yasumi, Murakami, Takashi, Imaizumi, Keiichiro, Eto, Nobuaki, Shimazaki, Kenji
Format Patent
LanguageEnglish
Published 20.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention is an orally administered adsorbent comprising activated carbon fiber, wherein the orally administered adsorbent is a drug for treating or preventing kidney disease, or a drug for treating or preventing dialysis complications.
AbstractList The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention is an orally administered adsorbent comprising activated carbon fiber, wherein the orally administered adsorbent is a drug for treating or preventing kidney disease, or a drug for treating or preventing dialysis complications.
Author Shimazaki, Kenji
Ohtaki, Akihito
Imaizumi, Keiichiro
Eto, Nobuaki
Murakami, Takashi
Nishiwaki, Yasumi
Author_xml – fullname: Ohtaki, Akihito
– fullname: Nishiwaki, Yasumi
– fullname: Murakami, Takashi
– fullname: Imaizumi, Keiichiro
– fullname: Eto, Nobuaki
– fullname: Shimazaki, Kenji
BookMark eNrjYmDJy89L5WSQ9S9KzMmpVEhMyc3MyywuSS1KTQFyivOLklLzSngYWNMSc4pTeaE0N4OKm2uIs4duakF-fGpxQWJyal5qSbxjqJGBoZGxoaWJpamTk5ExkcoApvcnkg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2012319495BB2
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2012319495BB23
IEDL.DBID EVB
IngestDate Fri Jul 19 14:36:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2012319495BB23
Notes Application Number: AU20120319495
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170720&DB=EPODOC&CC=AU&NR=2012319495B2
ParticipantIDs epo_espacenet_AU2012319495BB2
PublicationCentury 2000
PublicationDate 20170720
PublicationDateYYYYMMDD 2017-07-20
PublicationDate_xml – month: 07
  year: 2017
  text: 20170720
  day: 20
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies TEIJIN LIMITED
RelatedCompanies_xml – name: TEIJIN LIMITED
Score 3.1039572
Snippet The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or...
SourceID epo
SourceType Open Access Repository
SubjectTerms APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBONFILAMENTS
CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS,THREADS, FIBRES, BRISTLES OR RIBBONS
CHEMISTRY
COMPOUNDS THEREOF
HUMAN NECESSITIES
HYGIENE
INORGANIC CHEMISTRY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NATURAL OR ARTIFICIAL THREADS OR FIBRES
NON-METALLIC ELEMENTS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPINNING
TEXTILES
Title Orally administered adsorbent
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170720&DB=EPODOC&locale=&CC=AU&NR=2012319495B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JS8NAFH6UKupNq-IW6aHkFpykyaQ5FDEbRbAp0kpvZWYyASG0JYmI_943Q6o96W0WeLPAW76ZtwAMPBqMmMuo5RQjBCh2jnJQCNeSniwCpvwuhPbyndLJwn1eessOlLtYGJ0n9FMnR0SOEsjvjZbX299HrFj7VtYP_B2HNo_pfBybLTq2feI7xIzDcTLL4iwyowiRpDl9VXNoyQQIB0IU2AdoSPvKASx5C1VcynZfqaSncDhDeuvmDDpy3YPjaFd7rQdHL-2XNzZb7qvPwcgqVpZffdYmvFVlNrFTbyqOZC5gkCbzaGLhOqufY62eFnubCp3hJXQR8csr6AsibeHLgkhWuLTImePKgORMcm5Tng-vwfiT1M0_87dwou5KPVE65A66TfUhDdStDb_XV_INe-h81A
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JS8NAFH6UKtabVsUt2kPJLThJsx6KmKQhapsUSaW3MEkmUAhtSSLiv_dNSLUnvc0CbxZ4yzfzFoChplsmVakuKbmJAEXOUA6mqSoxjeUW5X4XaePlG-j-Qn1ZassOFLtYmCZP6GeTHBE5KkV-rxt5vf19xHIb38rqIVnh0ObRi8au2KJj2SCGQkTXHk_moRs6ouMgkhSDNz6HloyFcMBGgX2ARrbJM-1P3m0el7LdVyreCRzOkd66PoUOW_eh5-xqr_XhaNZ-eWOz5b7qDISwpEXxNaBtwlteZhM71aZMkMw5DL1J5PgSrhP_HCt-WuxtylZGF9BFxM8uYZASJqcGywmjuarnGVVUZpGMsiSR9SQbXYHwJ6nrf-bvoedHs2k8fQ5eb-CY3xt_rlTILXTr8oMJqGfr5K65nm991n_E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Orally+administered+adsorbent&rft.inventor=Ohtaki%2C+Akihito&rft.inventor=Nishiwaki%2C+Yasumi&rft.inventor=Murakami%2C+Takashi&rft.inventor=Imaizumi%2C+Keiichiro&rft.inventor=Eto%2C+Nobuaki&rft.inventor=Shimazaki%2C+Kenji&rft.date=2017-07-20&rft.externalDBID=B2&rft.externalDocID=AU2012319495BB2